“Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab over 52 Weeks”, J of Skin, vol. 2, no. S1, p. S14, Feb. 2018, doi: 10.25251/skin.2.supp.14.